<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40" class="p">Although geraniol and eugenol together accounted for only 1.5% of the 
 <italic class="italic">O. fragrans</italic> var. 
 <italic class="italic">thunbergii</italic> essential oil (Additional file 
 <xref rid="MOESM2" ref-type="media" class="xref">2</xref>), these two compounds showed potential of strong bioactivity and acceptable cytotoxicity at the level of quantity according to previous reports. Geraniol originated from geranium essential oil was reported to show 312.5 μg/mL minimum inhibitory concentrations (MIC) against many species of bacteria such as 
 <italic class="italic">E. coli, Mycobacterium smegmatis, Pseudomonas aeruginosa, Salmonella typhi,</italic> and 
 <italic class="italic">Yersinia enterocolitica</italic>. Moreover, 100 μg/mL strong activity of geraniol was also found against 
 <italic class="italic">Staphylococcus epidermidis</italic> and 
 <italic class="italic">Streptococcus mutans</italic> [
 <xref ref-type="bibr" rid="CR55" class="xref">55</xref>]. Inhibitory concentration 50% values (IC
 <sub xmlns="http://www.w3.org/1999/xhtml">50</sub>) for the anti-HSV effects of eugenol were 25.6 mg/mL and 16.2 mg/mL for HSV-1 and HSV-2 respectively, together with a maximum dose of 250 mg/mL for cytotoxicity test in the mouse model [
 <xref ref-type="bibr" rid="CR56" class="xref">56</xref>]. These reports supported the assumption that eugenol and geraniol were the main active ingredients of 
 <italic class="italic">O. fragrans</italic> var. 
 <italic class="italic">thunbergii</italic> essential oil.
</p>
